Scientific Posters
Welcome to OriGene AI!
I'm your AI-powered guide to everything OriGene.
Ask me anything:
- Product specs
- Ordering help
- Technical questions
- How to find exactly what your experiment needs
Prefer a live agent? Connect with us by clicking the green chat icon, as seen in the image below or email our team at custsupport@origene.com.
OriGene scientists are dedicated to the advancement of biological and medical science. They attend scientific conferences and share their ideas and findings with fellow scientists.
2024 American Association of Cancer Research
| Target of Interest | Title | View PDF |
|---|---|---|
| MAGE-A3, MAGE-A4, PD-L1 | MAGE-A3, MAGE-A4, and PD-L1 protein show co-expression in colon, lung and bladder cancer | |
| MAGE-A3, IDH1, IL_1β | MAGE-A3 co-expression with IDH1-R132H and IL-1β in colon cancer | |
| DEFB4A | Computational integration with phage library to optimize clones of DEFB4A antibodies for cancer diagnostics and therapeutics | |
| CRISPR | A Highly Efficient Donor System for CRISPR Knock-In Editing | |
| PSCA, PD-L1 | Exploring the relationship between PSCA and PD-L1 by a comprehensive tumor immunohistochemical analysis | |
| MAGE-A3, MAGE-A4 | Secretion of MAGE-A3 and MAGE-A4 in cell lines and lung cancer | |
| MAGE-A3 | MAGEA3 expression and secretion in MMR-MSH6 and MMR-PMS2 microsatellite-stable colorectal cancer |
2023 American Association of Cancer Research
| Target of Interest | Title | View PDF |
|---|---|---|
| MAGEA3 & MAGEA4 | MAGEA3 and MAGEA4 proteins show co-expression in lung, bladder and colon cancer. | |
| MAGEA3 | MAGE-A3 expression with MMR-MSH6 screening suggests MAGE-A3 as a potential target for microsatellite-stable colorectal cancer. | |
| MAGEA3 & MAGEA4 | Colocalization of MAGE-A3 and MAGE-A4 in bladder cancer. |
2022 National Society for Histotechnology
| Target of Interest | Title | View PDF |
|---|---|---|
| MAGEA3 and MAGEA4 | MAGEA3 and MAGEA4 have different expression pattern in lung cancer |
2022 American Association for Clinical Chemistry Meeting
| Target of Interest | Title | View PDF |
|---|---|---|
| MAGE-A3 | Serum MAGE-A3 Is A Potential Prognostic Marker for Prostate Cancer |
2022 American Association of Cancer Research Annual Meeting
2020 American Association of Cancer Research Virtual Annual Meeting
| Target of Interest | Title | View PDF |
|---|---|---|
| PD-L1 | PD-L1 and Diacylglycerol Kinase alpha (DGKa) Expression in NSCLC and Bladder Cancer |
2019 American Association of Cancer Research Annual Meeting
2018 American Association of Cancer Research Annual Meeting
| Target of Interest | Title | View PDF |
|---|---|---|
| PD-L1 | Characterization of Two New Recombinant Rabbit anti-PDL1 Antibodies In Bladder Cancer, NSCLC, and Melanoma With Immune Cell Markers CD3, CD8A, CD20, CD68 and FOXP3 |
2016 American Association of Cancer Research Annual Meeting
| Target of Interest | Title | View PDF |
|---|---|---|
| ALK | A new, highly sensitive ALK antibody improves the screening of rearranged-ALK by IHC | |
| LGR5 | Evaluation of LGR5 protein expression in colon cancer stem cells | |
| HER2 | A screen of breast and colon cancers with HER2 antibody clone UMAB36 does not exhibit the cross-reactivity of clone 4B5 with HER4 protein |
2015 American Association of Cancer Research Annual Meeting
| Target of Interest | Title | View PDF |
|---|---|---|
| ALK | The development of a highly sensitive mouse monoclonal antibody for screening ALK-rearrangements in lung cancers | |
| HER2 | Develop a Highly Specific HER2 Antibody for IHC Screening in Breast and Gastric Cancers | |
| Ki67 | The Development of a Highly Specific IHC Monoclonal Antibody against Ki-67 | |
| MET | The development of a highly specific mouse monoclonal MET antibody for IHC application |